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The most common
scenario for such
dilemmas involves
manuscripts that
contain significant
imperfections but
address a prevalent
and very important
clinical issue for
which virtually no
data are available.he principal role of the Editor-in-Chief and Associate Editors of a medical
journal is to select content. The most important responsibility relating to
content is to determine which of the many original research articles submitted
or review should be accepted for publication. As indicated previously, in the average
eek the editors of JACC will consider approximately 100 manuscripts, of which about
0 can be accepted for publication. Obviously, selecting these papers is a grueling task
hat requires not only assessment of the novelty and accuracy of the work, but judgment
bout the potential impact upon practice. The process is imperfect and papers frequently
resent issues that convey a degree of uncertainty and stress to the process of reaching a
ecision. In this regard, there are a few special issues that constitute particularly difficult
ilemmas.
The most common quandary encountered is when the reviewers disagree in their as-
essments. As has been reported in these pages previously, in nearly 40% of cases the
ritique of one expert external reviewer places the manuscript in the highest priority cat-
gory, whereas that of the other places it in the lowest. This represents something of a
ilemma because there is a danger of either missing a potentially very important paper
r accepting one with a serious flaw. When both referees make cogent agreements for
heir recommendation, we often seek a third opinion. Our resolution usually favors giv-
ng the author the benefit of the doubt. Nevertheless, it is always difficult to override the
dvice of a respected reviewer who unequivocally advocates rejection of a manuscript.
The most difficult dilemmas, however, often occur when the facts are not in question
nd two reviewers are in complete agreement. In fact, the Associate Editor usually con-
urs as well in such instances. The most common scenario for such dilemmas involves
anuscripts that contain significant imperfections but address a prevalent and very im-
ortant clinical issue for which virtually no data are available. Typically, such studies
ntail large patient groups but are retrospective and uncontrolled. Accordingly, they are
usceptible to important variables whose influence cannot be assessed. Such studies often
pply propensity analysis in an attempt to deal with the uncontrolled variables, a maneu-
er that greatly strengthens the paper but is ultimately limited and not definitive. The
ditors are left with a paper that provides some useful data regarding the clinical issue,
ut no clear direction for clinical action.
While not discussing specific manuscripts, a few examples can illustrate the dilemma
learly. Imagine a common chronic cardiac condition for which periods of stability are
nterrupted by episodes of decompensation. When stable, the patients are often treated
ith agents that may be detrimental (or beneficial) during periods of decompensation.
owever, no data exist as to whether one should discontinue the agents during decom-
ensation. A manuscript is received that reports the retrospectively analyzed outcomes of
large group of patients in whom the agents were either stopped or carried on. The
aper provides useful information regarding the end results of patients so managed, but
t cannot eliminate the variable of why the individual patients received the treatment
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October 16, 2007:1610–1 Editor’s Pagehat was given. As another example, consider two preva-
ent conditions that not uncommonly occur in the same
ndividual. Each disorder warrants prophylactic treatments
hat may lead to adverse effects in combination. However,
o data exist as to whether one (or other) of the therapies
hould be discontinued when the two conditions coexist.
manuscript is received that reports the outcome of a
arge number of patients in whom one, or the other, or
oth agents were administered. Again, the variable of why
he management was selected in any individual case pre-
ents preferable management strategies from being de-
ived. Many other illustrations could be given.
The common denominator of the foregoing examples is
mperfect data regarding common clinical problems for
hich little or no evidence is available as to optimal man-
gement. The editors are confronted with the dilemma of
hether some information is better than none. On the
ne hand, the observational data can provide some guid-
nce for decision making, at least in regard to relative
afety. On the other hand, the data are clearly not capable
f resolving the issue, and may be misinterpreted to be
ore definitive than they are. To complicate the matter,
uch papers often provide the only available data for com-
on clinical problems and thus are likely to be frequently
ited and reflect well on the Journal. As might be ex-
ected, these manuscripts stimulate some of the longest
nd most spirited discussions of the editors.
There are, of course, other dilemmas that often con-
ront the editors. One of the most difficult relates to
anuscripts that are similar to others published by the
ame authors, so similar in fact that they raise the issue of
uplicate publication. Such papers are never identical, and
lways differ in at least some small aspect. However, they
ypically originate from the same database and provide
ubstantially overlapping findings. More than just rejec-
ion, the issues include the consequences to the authors if Euplicate publication is determined to be present. The
ditors tread very cautiously here, and try to give the au-
hors every benefit of the doubt. Another cause of quan-
ary is the manuscript reporting findings that are abso-
utely predictable, but have never before been published.
o we serve our readers well by documenting the obvi-
us? In the same vein, the paper with incremental find-
ngs also creates a predicament. Should we reject a manu-
cript that is well done and accurate but advances the
eld only a small amount? Unfortunately, our page limita-
ions often dictate that we do so.
Nevertheless, all of these other dilemmas pale com-
ared to the potential positive (or negative) impact of pa-
ers presenting the solitary data on common unresolved
linical issues. I wish that I could say that after 5 years
nd over 20,000 manuscripts we had evolved a clear path-
ay to reaching decisions on these papers. In fact, it is
till a case-by-case process. In general, however, we have
ended to put the data out there and let the readers de-
ide for themselves. Still, it is a bit disappointing to real-
ze that, despite all the work and efforts of the authors,
eviewers, and editors (alone and in combination), uncer-
ainty and ambivalence often exists regarding whether the
ecision to publish was correct. Editors are sometimes
hought to act “like God” in deciding whether a manuscript
ill be published or not. It is clear to me, however, that with
egard to the dilemmas with which we deal, we still lack
mniscience.
ddress correspondence to:
r. Anthony N. DeMaria
ditor-in-Chief, Journal of the American College of Cardiology
655 Nobel Drive, Suite 630, San Diego, California 92122
-mail: ademaria@acc.org
